Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 127   

Articles published

SHP 3,708.86 -39.64 (-1.06%)
price chart
Shire heads higher on reports activist hedge fund demands divestments
Shire Plc (LON:SHP) advanced on Monday morning after weekend reports that an activist US hedge fund is demanding a string of divestments at the multi-billion pound biotech.
Generic Restasis Risk Metastasizes To Shire
The RESTASIS patent invalidation-stoked selling in Allergan (-4.7%) has spread to Shire plc (-3.6%) as investors perceive generic encroachment on its Xiidra (lifitegrast ophthalmic solution) franchise.
Shire plc : Notice of Results
Dublin, Ireland - October 12, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG), will announce third quarter 2017 earnings on Friday October 27, 2017.
Shire PLC (ADR) (SHPG) in the Spotlight as Activist Fund Sachem Pushes For ...  Insider Monkey (blog)
Shire PLC (SHPG) Holdings Decreased by Arrowstreet Capital Limited Partnership  Dispatch Tribunal
Shire Q3/2017: Earnings Preview
I will preview the earnings report in comparison with sell-side expectations, to show why I believe Q3/2017 expectations need to be slightly revised down.
Shire plc : New Formulation of ONCASPAR� (pegaspargase) Receives Positive CHMP ...
If approved, lyophilized formulation would offer three times longer shelf life vs. liquid ONCASPAR, enabling better supply management and improved product availability.
Shire plc : Total voting rights
As at September 30, 2017, the Company's issued ordinary share capital comprised 908,509,840 ordinary shares of 5 pence each with voting rights and a further 7,357,283 ordinary shares held in treasury.
Keep Patience On Shire
At Q2/2017 Results, Shire announced that the management would implement a strategic review of the ADHD unit. The NPV valuation of the ADHD franchise is around $10B.
Iowa State Bank Buys Shire PLC, Workiva Inc, BioTime Inc, Sells EI ...
Iowa State Bank initiated holdings in Shire PLC. The purchase prices were between $140.85 and $169.8, with an estimated average price of $156.9.
Shire sues Allergan in US over dry eye drug
(Reuters) - Allergan Plc was sued on Monday by Shire Plc for allegedly scheming to block doctors from prescribing its new treatment for dry eye disease.
Shire sues Allergan for antitrust suit  MarketWatch
PRESS: Shire Sues Allergan Over Dry Eye Disease Drug - Reuters  Interactive Investor
Shire officially inks sublease for former Ariad site in Cambridge
The Business Journal reported in early August that Shire was nearing a deal to sublease the space. At the time, Shire CEO Flemming Ornskov declined to confirm the sublease, but acknowledged that the company was looking for additional lab space in order ...